CSU secures award for development of SolaVAX vaccine manufacturing process for #COVID19

A team of infectious disease researchers at Colorado State University has entered into an agreement with the Biomedical Advanced Research and Development Authority (BARDA) to further develop a novel virus inactivation process, successfully used for MERS, which has the potential to inactivate the #COVID19 virus.

Click HERE for the full story.